Recursion Pharmaceuticals SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

424B5Oct. 15, 2026, 5:31 p.m. ETView on SEC.gov
8-KOct. 15, 2026, 8:46 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Results of operations and financial condition · Regulation FD disclosure · Other events · Financial statements and exhibits
424B5Oct. 15, 2026, 8:19 a.m. ETView on SEC.gov
4Oct. 7, 2026, 6:08 p.m. ETView on SEC.gov
4Oct. 7, 2026, 6:08 p.m. ETView on SEC.gov
4Oct. 2, 2026, 6:17 p.m. ETView on SEC.gov
4Oct. 2, 2026, 6:17 p.m. ETView on SEC.gov
8-KSept. 21, 2026, 9:05 a.m. ETView on SEC.gov
Entry into a material definitive agreement
4Sept. 16, 2026, 5:52 p.m. ETView on SEC.gov
4Sept. 10, 2026, 5:55 p.m. ETView on SEC.gov
4Sept. 2, 2026, 6:01 p.m. ETView on SEC.gov
4Aug. 18, 2026, 5:44 p.m. ETView on SEC.gov
4Aug. 18, 2026, 5:44 p.m. ETView on SEC.gov
4Aug. 18, 2026, 5:44 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 7, 2026, 10:48 a.m. ETView on SEC.gov
4Aug. 6, 2026, 5:09 p.m. ETView on SEC.gov
10-QAug. 5, 2026, 6:32 a.m. ETView on SEC.gov
8-KAug. 5, 2026, 6:31 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
SCHEDULE 13GJuly 31, 2026, 11:40 a.m. ETView on SEC.gov
SCHEDULE 13GJuly 31, 2026, 10:42 a.m. ETView on SEC.gov
SCHEDULE 13G/AJuly 29, 2026, 3:19 p.m. ETView on SEC.gov